NFKB1 and depressive symptom measurement: And the antidepressants obviously alleviated CUMS-induced depression-like behavior and exerted considerable neuroprotective effects by regulating the microglial state transition by inhibiting the TLR4/MyD88/NF-κB signaling pathway [28].